Abstract
During the 1970s, when the institutional review board (IRB) process was newly the law of the land, clinical trials done by a single investigator at a single institution were the norm. Today’s trials, however, are more often enterprises in which networks of investigators at hundreds or even thousands of institutions collaborate.

This publication has 0 references indexed in Scilit: